093 Look on the hold of heart failure management in Morocco, about 294 patient

Objectivethe objective was to identify the epidemiological, clinical and the outcome of heart failure (HF) in a Moroccan hospital.MethodA retrospective study using a serie of 294 patients hospitalized in our service from January 2005 to December 2008.ResultsThe HF occupies 14% of hospitalizations. The mean length of stay was 14±3.1 days. The mean age was 58±11.5 years. Men were mostly represented with a ratio H / F=3.5. The main cardiovascular risk factor was smoking (55%) followed by hypertension (40%) and diabetes (35%). Dyspnea was the main symptom reported in 91% of the cases. The clinical presentation was that of left (65%), right (22%) and global(23%) HF. Among electric signs, we found Atrial fibrillation (30%), a Q-wave (58%) and left ventricular hypertrophy (28%). the chest x-ray showed a cardiomegaly (89%) and signs of pulmonary overload (86%). Biology showed electrolyte abnormalities in half of the cases, renal failure (35%) and anemia (28%). In echocardiography, the mean left ventricular ejection fraction (LVEF) was 34.5±5.4%. LVEF was > 45% for 26% of patients. 134 patients underwent a coronary angiography which objectified coronary damage in 84% of the cases. The main causes were ischemic heart disease (42%), valvular heart disease(24%) and hypertension (13%). most used drugs were angiotensin converting enzym inhibitors and diuretics. 21% of patients underwent a mitral valve replacement with mechanical prosthesis. Among patients with coronary artery disease, 33% were revascularized by coronary bypass (21%) and coronary angioplasty (12%). Cardiac resynchronization was performed for 19 patients using implantable automatic defibrillator for 3 of them.Hospital mortality was 10%.ConclusionThe main features of this population is the relatively young age, male predominance, ischemic heart disease as a leading cause and low rate of HF with preserved systolic function

Rare case of cardiac angiosarcoma and alveolar hemorrhage in an adolescent patient initially suspected COVID19 infection: A case report and literature review

Primary cardiac tumors are a rarity, and sarcomas emerge as the prevailing form of primary malignant cardiac tumors across age groups, encompassing both children and adults. Within this category, angiosarcoma stands out, constituting around 31% of all primary malignant cardiac tumors. Primary cardiac angiosarcoma displays a notably aggressive nature, characterized by early systemic metastasis, and is accompanied by a generally unfavorable prognosis.We describe a case concerning a previously healthy teenage girl who displayed persistent constitutional symptoms and hemoptysis for 15 days. Subsequent investigation uncovered alveolar hemorrhage, ultimately linked to a cardiac angiosarcoma. The difficulty in this instance arose from the vague nature of the initial symptoms, posing a challenge to promptly and accurately diagnose the condition.This case highlights the aggressive nature of primary cardiac angiosarcoma. The vague initial symptoms underscore the need for early detection and optimized treatment to improve the generally unfavorable prognosis associated with this condition. Increased awareness and a multidisciplinary approach are crucial in addressing the diagnostic and therapeutic challenges posed by primary cardiac angiosarcoma

The national moroccan registry of ST-elevation myocardial infarction (MR-MI)

Abstract Background MR-MI is the first national Moroccan ST-elevation myocardial infarction (STEMI) registry. Its objectives are to assess patient management modalities and highlight the clinical and therapeutic characteristics of this pathology in all cardiology centres on a national scale. Methods Adult patients presenting with STEMI within 5 days of symptoms onset were enrolled over a period of 18 weeks from April to August 2018. 57 cardiology centres distributed in 22 cities in Morocco participated in the study, including 5 university hospitals, representing 70% of Moroccan centres managing STEMI patients. A case report form was sent to the investigators in both electronic and paper forms. Sociodemographic, clinical, management, revascularization, and follow-up data were collected. Results A total of 809 patients were recruited. The population was mostly male (74.8%) with an average age of 62.6 ± 11.6 years. The most common risk factors were smoking (38.3%) arterial hypertension (30.7%), and diabetes (28%). 30% of patients were admitted within the first 6 h of symptoms onset and early revascularization was performed on 49.6%. Mortality rate was 5.2% in-hospital and 3.2% at the one-month follow-up. Conclusion MR-MI is the first Moroccan STEMI registry on a national scale. Relevant management delays are much longer than other countries, and less than 50% of the patients that present on time benefit from early revascularization. Efforts remain to be done on the optimal diagnosis and treatment of STEMI

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) : The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate

2019 ESC guidelines for the dignosis and management of acute pulmonary embolism developed in collaboration with the european respiratory society (ERS)

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate